awards grant Study aims to restore patient's ejection fraction through prophylactic use of Impella during a non-emergent PCI (ProPCI). Study hypothesizes that the use of ProPCI leads to a significant improvement of the patients left ventricular ejection fraction (LVEF) through the course of study.
